[Therapy of osteodystrophia deformans (Paget's disease)].
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000209:etiology; D002114:Calcinosis / Q000517:prevention & control; D002116:Calcitonin / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004872:Ergocalciferols / Q000627:therapeutic use; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D006934:Hypercalcemia / Q000517:prevention & control; D007669:Kidney Calculi / Q000517:prevention & control; D008175:Lung Neoplasms / Q000209:etiology; D008297:Male; D009362:Neoplasm Metastasis; D010001:Osteitis Deformans / Q000150:complications / Q000188:drug therapy*; D008926:Plicamycin / Q000627:therapeutic use; D011033:Podophyllin / Q000627:therapeutic use; D011809:Quinones / Q000627:therapeutic use; D012509:Sarcoma / Q000209:etiology; D014807:Vitamin D / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004872:Ergocalciferols; D011809:Quinones; D014807:Vitamin D; D002762:Cholecalciferol; D003520:Cyclophosphamide; D011033:Podophyllin; D002116:Calcitonin; D008926:Plicamycin
La terapia dell'osteodistrofia deformante (malattia di Paget)